Cost Of Sales Changement Date
AbbVie USD 4.28B 90M 2023-12
Acadia Pharmaceuticals USD 17.89M 3.27M 2023-12
Acorda Therapeutics USD 3.06M 169K 2023-06
ALKERMES USD 61.51M 1.75M 2023-09
Amgen USD 3.11B 1.31B 2023-12
Biogen USD 618.3M 41.3M 2023-12
BioMarin Pharmaceutical USD 135.48M 10.73M 2023-12
Bluebird Bio USD 10.96M 1.39M 2023-09
Bristol-Myers Squibb USD 2.71B 217M 2023-12
Eli Lilly USD 1.79B 72.1M 2023-12
Gilead Sciences USD 1.61B 46M 2023-12
Heron Therapeutics USD 18.21M 1.95M 2023-09
Intra Cellular Therapies USD 10.7M 1.57M 2023-12
Ionis Pharmaceuticals USD 3.06M 871K 2023-12
J&J USD 6.8B 418M 2023-12
Malin Corporation EUR 15.4M 0 2020-12
Marinus Pharmaceuticals USD 455K 69K 2023-09
Merck USD 3.34B 891M 2023-12
Nektar Therapeutics USD 12.43M 5.44M 2023-09
Neurocrine Biosciences USD 11.2M 300K 2023-09
Otsuka Holdings JPY 157.49B 6.4B 2023-09
Pfizer USD 6.66B 2.24B 2023-12
Regeneron Pharmaceuticals USD 517M 80.6M 2023-12
Revance Therapeutics USD 19.41M 1.89M 2023-09
Vertex Pharmaceuticals USD 318.7M 10.1M 2023-09



ALKERMES Le Coût Des Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.